- Home
- IKT vs NCTY Comparison
IKT vs NCTY Comparison
Compare IKT & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- NCTY
- Stock Information
- Founded
- IKT 2008
- NCTY 1999
- Country
- IKT United States
- NCTY China
- Employees
- IKT N/A
- NCTY N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- NCTY Business Services
- Sector
- IKT Health Care
- NCTY Consumer Discretionary
- Exchange
- IKT Nasdaq
- NCTY Nasdaq
- Market Cap
- IKT 140.5M
- NCTY 121.2M
- IPO Year
- IKT 2020
- NCTY 2004
- Fundamental
- Price
- IKT $1.56
- NCTY $10.02
- Analyst Decision
- IKT Buy
- NCTY
- Analyst Count
- IKT 2
- NCTY 0
- Target Price
- IKT $8.00
- NCTY N/A
- AVG Volume (30 Days)
- IKT 92.1K
- NCTY 57.4K
- Earning Date
- IKT 11-13-2025
- NCTY 01-01-0001
- Dividend Yield
- IKT N/A
- NCTY N/A
- EPS Growth
- IKT N/A
- NCTY N/A
- EPS
- IKT N/A
- NCTY N/A
- Revenue
- IKT N/A
- NCTY $15,305,175.00
- Revenue This Year
- IKT N/A
- NCTY N/A
- Revenue Next Year
- IKT N/A
- NCTY N/A
- P/E Ratio
- IKT N/A
- NCTY N/A
- Revenue Growth
- IKT N/A
- NCTY N/A
- 52 Week Low
- IKT $1.12
- NCTY $6.28
- 52 Week High
- IKT $4.20
- NCTY $20.59
- Technical
- Relative Strength Index (RSI)
- IKT 42.51
- NCTY 55.26
- Support Level
- IKT $1.50
- NCTY $9.06
- Resistance Level
- IKT $1.73
- NCTY $11.20
- Average True Range (ATR)
- IKT 0.09
- NCTY 0.73
- MACD
- IKT -0.02
- NCTY 0.13
- Stochastic Oscillator
- IKT 17.34
- NCTY 55.13
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.